| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/08/2001 | CA2376245A1 Binding moieties for fibrin |
| 02/07/2001 | EP1074625A2 DNA vaccine against feline immunodeficiency virus |
| 02/07/2001 | EP1074624A1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
| 02/07/2001 | EP1074614A1 A recombinant Newcastle disease virus for in ovo vaccination |
| 02/07/2001 | EP1074613A1 Lentivirus from the group of immunodeficiency viruses from drill apes (Mandrillus leucophaeus) and its use |
| 02/07/2001 | EP1074563A1 Chimeric polypeptides enhancing dimer formation through electrostatic interactions and disulfide bond, method for production and uses thereof |
| 02/07/2001 | EP1073760A1 Adenovirus mutants with deleted protease gene, complementing cell lines and corresponding vectors for gene transfer |
| 02/07/2001 | EP1073759A1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof |
| 02/07/2001 | EP1073758A1 Retroviral vectors including modified envelope escort proteins |
| 02/07/2001 | EP1073721A1 Efficient purification of adenovirus |
| 02/07/2001 | EP1073461A1 Viral chimeras comprised of caev and hiv-1 genetic elements |
| 02/07/2001 | EP1073442A1 Combination viral-based and gene-based therapy of tumors |
| 02/07/2001 | CN1283233A Variant loxP sequences and application of the same |
| 02/07/2001 | CN1283223A Preparation of cells for production of biologicals |
| 02/06/2001 | US6184025 Nucleotide sequences for the detection and diagnosis of viral diseases |
| 02/06/2001 | US6184024 Expression vectors which code for viral heterologous proteins; for the development of vaccine for humans against dengue virus and other viral diseases |
| 02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
| 02/06/2001 | US6183753 Recombinant chimeric virus and uses thereof |
| 02/06/2001 | US6183750 Vaccines; gene expression |
| 02/03/2001 | CA2314466A1 Lentivirus from the group of immunodeficiency viruses of drill monkeys (mandrillus leucophaeus) and their use |
| 02/01/2001 | WO2001007637A2 Conditionally controlled, attenuated hiv vaccine |
| 02/01/2001 | WO2001007472A1 Highly purified cytokine activating factor and methods of use |
| 02/01/2001 | WO2000061736A3 Recombinant and mutant marek's disease virus |
| 02/01/2001 | CA2379251A1 Highly purified cytokine activating factor and methods of use |
| 01/31/2001 | EP1072010A2 Oligonucleotide mediated nucleic acid recombination |
| 01/31/2001 | EP1071827A1 Mixed cell diagnostic systems |
| 01/31/2001 | EP1071804A1 Use of triplex structure dna sequences for transferring nucleotide sequences |
| 01/31/2001 | EP1071758A1 Porcine adenovirus type 3 genome |
| 01/31/2001 | EP1071709A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 01/31/2001 | EP0706569B1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
| 01/31/2001 | CN1281863A Recombinant Newcastle disease virus capable of being used as embryo vaccine |
| 01/31/2001 | CN1061377C Monobleb viras carrier capable of being used in packaging recombination of adenovirus concomitant virus and use thereof |
| 01/30/2001 | US6180389 Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180343 Green fluorescent protein fusions with random peptides |
| 01/30/2001 | US6180110 Attenuated hepatitis a virus vaccine which grows in MRC-5 cells |
| 01/30/2001 | US6180109 Nucleotide and polypeptide sequences of pestivirus strains |
| 01/30/2001 | US6180098 Recombinant helicoverpa baculoviruses expressing heterologous DNA |
| 01/27/2001 | CA2312626A1 A recombinant newcastle disease virus as an embryo vaccine |
| 01/25/2001 | WO2001005992A1 Virus vectors and preparations and their uses |
| 01/25/2001 | WO2001005991A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 01/25/2001 | WO2001005990A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 01/25/2001 | WO2001005950A2 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 01/25/2001 | WO2001005835A1 Inactivated vaccine against feline calicivirus disease |
| 01/25/2001 | WO2000065034A3 Pseudotyped retroviral vector for gene therapy of cancer |
| 01/25/2001 | WO2000057908A3 Attenuated dengue-1 virus vaccine |
| 01/25/2001 | DE19933719A1 Strukturprotein in Adeno-assoziiertem Virus mit veränderten chromatographischen Eigenschaften, seine Herstellung und Verwendung Structural protein in adeno-associated virus with altered the chromatographic properties, its preparation and use |
| 01/24/2001 | EP1070123A2 Herpes simplex virus latency associated transcript polypeptides |
| 01/24/2001 | EP1070118A1 Modified adenovirus containing a fiber replacement protein |
| 01/24/2001 | EP1069908A2 Methods and modified cells for the treatment of cancer |
| 01/24/2001 | EP0904392B1 Retroviral vectors |
| 01/24/2001 | CN1281512A Selective killing and diagnosis of P53+ neoplastic cells |
| 01/24/2001 | CN1281371A Method for obtaining vaccines for preventing pathogenic effects related to retroviral infection |
| 01/24/2001 | CN1281336A Treatment of neoplasms with viruses |
| 01/24/2001 | CN1061093C Incasing cell series for prodn. of recombined adenovirus accompanying virus, and application thereof |
| 01/23/2001 | US6177270 Reaction-based selection for expression of and concentration of catalytic moieties |
| 01/23/2001 | US6177082 Cold-adapted equine influenza viruses |
| 01/23/2001 | US6177081 Human and marmoset activating viruses |
| 01/23/2001 | US6177075 Insect viruses and their uses in protecting plants |
| 01/18/2001 | WO2001004335A2 Human-bovine chimeric respiratory syncytial virus vaccines |
| 01/18/2001 | WO2001004333A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 01/18/2001 | WO2001004332A1 Method to improve viral infection |
| 01/18/2001 | WO2001004321A1 Production of attenuated respiratory syncytial virus vaccines involving modification of m2 orf2 |
| 01/18/2001 | WO2001004320A1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/18/2001 | WO2001004319A1 Mosaic infectious bursal disease virus vaccines |
| 01/18/2001 | WO2001004304A1 Human cytokine receptor |
| 01/18/2001 | WO2001004282A2 Replication-competent anti-cancer vectors |
| 01/18/2001 | WO2001004272A1 Method to select attenuated paramyxoviridae useful for vaccines and therapeutics |
| 01/18/2001 | WO2001004271A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | WO2001004266A1 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| 01/18/2001 | WO2001004136A1 Molecular determinants of tropism and virulence in enteroviruses |
| 01/18/2001 | WO2001003744A2 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of the c, d or v genes |
| 01/18/2001 | WO2000060050A3 Recombinant influenza viruses for vaccines and gene therapy |
| 01/18/2001 | WO2000057904A3 Attenuated dengue-3 virus vaccine |
| 01/18/2001 | WO2000039304A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/18/2001 | DE19933288A1 Strukturprotein von Adeno-assoziiertem Virus mit veränderter Antigenität, seine Herstellung und Verwendung Structural protein of adeno-associated virus with altered antigenicity, its preparation and use |
| 01/18/2001 | CA2379362A1 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | CA2379221A1 Molecular determinants of tropism and virulence in enteroviruses |
| 01/18/2001 | CA2379059A1 Mosaic infectious bursal disease virus vaccines |
| 01/18/2001 | CA2379012A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 01/18/2001 | CA2378661A1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/18/2001 | CA2378552A1 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 01/17/2001 | EP1069187A1 Mosaic Infectious Bursal Disease Virus vaccines |
| 01/17/2001 | EP1068799A2 Biological models capable of exhibiting secondary disease manifestations |
| 01/17/2001 | EP1068362A1 Hepatitis c virus ns5b compositions and methods of use thereof |
| 01/17/2001 | EP1068338A2 Enhanced prodrug activation |
| 01/17/2001 | EP1068330A2 Recombinant potyvirus construct and use thereof |
| 01/17/2001 | EP0672158B1 Adenovirus with genetic fusion of penton fibre to peptide altering binding specificity |
| 01/17/2001 | CN1280188A Continuous producing method of recombined phage in biologicl film reactor |
| 01/17/2001 | CN1060811C Autonomic replicating vector for construction of recombinant adenovirus concomitant virus packaging system and use thereof |
| 01/17/2001 | CN1060810C Formation of plasmid-type herpes-virus carrier for specific expression of human nerve cell and use of same |
| 01/16/2001 | US6174871 Gene therapies for enhancing cardiac function |
| 01/16/2001 | US6174527 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 01/16/2001 | CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/11/2001 | WO2001002592A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 01/11/2001 | WO2001002551A2 Virus like particles, preparation and use in screening and functional genomics |
| 01/11/2001 | WO2001002548A2 Methods for the propagation of lytic organisms |
| 01/11/2001 | WO2001002431A1 Recombinant adenovirus |
| 01/11/2001 | WO2000032226B1 Xenograft animal model for the induction of papillomas, the production of papillomavirus and the propagation thereof |
| 01/11/2001 | WO2000029561A8 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |